Who we are

We are an Oxford, UK-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology.

Our novel network-driven methodology allows us to discover new and better drugs in a more efficient and effective way.

We use our highly productive drug Discovery Engine to develop our own IP-protected, preclinical drug discovery programmes which will be of interest to partners looking to acquire or in-license novel and differentiated assets.

Because of our novel network-driven drug discovery (NDD) approach, we believe there is potential to enter into several different types of collaborative partnerships with biotech, pharma and other technology companies to create sustainable mutual value.

Read more
Share price
Read more
Our latest reports
All Reports

Latest news

Director/PDMR Shareholding

Director Shareholding

E-Therapeutics enters two AI collaborations

Non Regulatory Announcement

Partnering & Collaboration

e-therapeutics is presently seeking development and commercialisation partners for both its clinical and preclinical assets.

For more information on our licensing opportunities please contact bd@etherapeutics.co.uk